Difference between revisions of "MEDICATION-LIGNOCAINE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 1: | Line 1: | ||
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.<div>2. Indications: VF/pulseless or VT refractory to defibrillation.</div><div><br></div><div>SE</div><div>3. Nausea & vomiting.</div><div>4. CNS: slurred speech, drowsiness, seizures.</div><div>5. CVS: bradycardia, heart block, asystole. </div><div><br></div><div>DOSAGE</div><div>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered. </div> | <div>1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.<div>2. Indications: VF/pulseless or VT refractory to defibrillation.</div><div><br></div><div>SE</div><div>3. Nausea & vomiting.</div><div>4. CNS: slurred speech, drowsiness, seizures.</div><div>5. CVS: bradycardia, heart block, asystole. </div><div><br></div><div>DOSAGE</div><div>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered. </div> | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Revision as of 11:50, 15 December 2022
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
2. Indications: VF/pulseless or VT refractory to defibrillation.
SE
3. Nausea & vomiting.
4. CNS: slurred speech, drowsiness, seizures.
5. CVS: bradycardia, heart block, asystole.
DOSAGE
6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.
